Molson Coors Beverage Company logo

Molson Coors Beverage Company (TAP)

Market Closed
5 Dec, 20:00
NYSE NYSE
$
45. 13
-0.44
-0.97%
$
9.38B Market Cap
14.76 P/E Ratio
1.76% Div Yield
2,174,841 Volume
5.67 Eps
$ 45.57
Previous Close
Day Range
44.96 45.62
Year Range
42.94 64.66
Want to track TAP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 68 days
Molson Coors' focus on pushing premium brands leads to upbeat profit outlook

Molson Coors' focus on pushing premium brands leads to upbeat profit outlook

Molson Coors saw higher prices helping to offset continued volume declines.

Marketwatch | 9 months ago
Here's Why Molson Coors Brewing (TAP) is a Strong Value Stock

Here's Why Molson Coors Brewing (TAP) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 9 months ago
Molson Coors Pre-Q4 Earnings Review: Buy the Stock or Stay Patient?

Molson Coors Pre-Q4 Earnings Review: Buy the Stock or Stay Patient?

TAP Q4 results to reflect gains from strong brands, market share growth, innovation and digital efforts despite macroeconomic pressures in the U.S. beer market.

Zacks | 9 months ago
Stay Ahead of the Game With Molson Coors (TAP) Q4 Earnings: Wall Street's Insights on Key Metrics

Stay Ahead of the Game With Molson Coors (TAP) Q4 Earnings: Wall Street's Insights on Key Metrics

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Molson Coors (TAP), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2024.

Zacks | 9 months ago
Earnings Preview: Molson Coors Brewing (TAP) Q4 Earnings Expected to Decline

Earnings Preview: Molson Coors Brewing (TAP) Q4 Earnings Expected to Decline

Molson Coors (TAP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 10 months ago
Molson Coors Teams Up With Fever-Tree in Strategic U.S. Partnership

Molson Coors Teams Up With Fever-Tree in Strategic U.S. Partnership

TAP expands its non-alcoholic portfolio with a strategic partnership and investment in Fever-Tree, targeting growth in the U.S. market.

Zacks | 10 months ago
Will Molson Coors (TAP) Beat Estimates Again in Its Next Earnings Report?

Will Molson Coors (TAP) Beat Estimates Again in Its Next Earnings Report?

Molson Coors (TAP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks | 10 months ago
Here's Why Molson Coors Brewing (TAP) is a Strong Value Stock

Here's Why Molson Coors Brewing (TAP) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 10 months ago
Molson Coors Rises 7% in 6 Months: Should You Buy, Hold or Avoid?

Molson Coors Rises 7% in 6 Months: Should You Buy, Hold or Avoid?

TAP makes significant progress against the Acceleration Plan. It is focused on portfolio premiumization as well.

Zacks | 10 months ago
Why Molson Coors Brewing (TAP) is a Top Value Stock for the Long-Term

Why Molson Coors Brewing (TAP) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 11 months ago
Molson Coors Trades Below 200 & 50-Day SMA: How to Play the Stock

Molson Coors Trades Below 200 & 50-Day SMA: How to Play the Stock

TAP's revitalization plan shows resilience amid U.S. pressures, with strong earnings growth and promising global expansion.

Zacks | 11 months ago
U.S. surgeon general calls for cancer risk warnings on alcohol labels

U.S. surgeon general calls for cancer risk warnings on alcohol labels

The U.S. surgeon general on Friday issued a new advisory warning about the link between alcohol consumption and increased cancer risk. Surgeon General Dr. Vivek Murthy called additions to labels warning of the connection between alcohol use and cancer risk.

Cnbc | 11 months ago
Loading...
Load More